These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20450292)

  • 1. Stent design matters: insights from virtual bench testing.
    Mortier P; Verdonck PR
    Expert Rev Cardiovasc Ther; 2010 May; 8(5):613-5. PubMed ID: 20450292
    [No Abstract]   [Full Text] [Related]  

  • 2. Newer stents: looking at the horizon.
    Ramcharitar S; Serruys PW
    Indian Heart J; 2007; 59(2 Suppl B):B59-71. PubMed ID: 19153438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemodynamics analysis of intravascular stents with different design features].
    Liang D; Yang D
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Dec; 23(6):1241-4. PubMed ID: 17228717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting stents for coronary bifurcations: bench testing of provisional side-branch strategies.
    Ormiston JA; Webster MW; El Jack S; Ruygrok PN; Stewart JT; Scott D; Currie E; Panther MJ; Shaw B; O'Shaughnessy B
    Catheter Cardiovasc Interv; 2006 Jan; 67(1):49-55. PubMed ID: 16003787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-eluting balloon: from bench to bed.
    De Labriolle A; Pakala R; Bonello L; Lemesle G; Scheinowitz M; Waksman R
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):643-52. PubMed ID: 19309715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary bifurcation lesions: innovative approaches and the future of bifurcation devices.
    Cortese B; Limbruno U
    Future Cardiol; 2010 Mar; 6(2):221-30. PubMed ID: 20230263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug release from coronary eluting stents: A multidomain approach.
    Vairo G; Cioffi M; Cottone R; Dubini G; Migliavacca F
    J Biomech; 2010 May; 43(8):1580-9. PubMed ID: 20185137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design criteria for the ideal drug-eluting stent.
    Ako J; Bonneau HN; Honda Y; Fitzgerald PJ
    Am J Cardiol; 2007 Oct; 100(8B):3M-9M. PubMed ID: 17950830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stents for coronary bifurcations: insights into the crush technique.
    Ormiston JA; Currie E; Webster MW; Kay P; Ruygrok PN; Stewart JT; Padgett RC; Panther MJ
    Catheter Cardiovasc Interv; 2004 Nov; 63(3):332-6. PubMed ID: 15505853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradable, drug-eluting stents: a new frontier for the treatment of coronary artery disease.
    Kohn J; Zeltinger J
    Expert Rev Med Devices; 2005 Nov; 2(6):667-71. PubMed ID: 16293093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of drug-eluting stent restenosis: a sandwich may not be the best combo.
    Belardi J
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):599. PubMed ID: 18360848
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-eluting stent safety.
    Slottow TL; Waksman R
    Am J Cardiol; 2007 Oct; 100(8B):10M-17M. PubMed ID: 17950827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based management of patients undergoing PCI: stent controversies.
    Vetrovec GW
    Catheter Cardiovasc Interv; 2010 Mar; 75 Suppl 1():S39-42. PubMed ID: 20333706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bioabsorbable stent as a virtual prosthesis.
    Colombo A; Sharp AS
    Lancet; 2009 Mar; 373(9667):869-70. PubMed ID: 19286066
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent restenosis after implantation of sirolimus-eluting stents in aorto-ostial lesions: successful treatment with polytetrafluoroethylene-covered stents.
    Gagnor A; Varbella F; Rubartelli P; Luceri S; Conte MR
    J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):201-4. PubMed ID: 18192816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical appraisal of the safety and efficacy of drug-eluting stents.
    Maluenda G; Lemesle G; Waksman R
    Clin Pharmacol Ther; 2009 May; 85(5):474-80. PubMed ID: 19279567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary bifurcation stenting: insights from in vitro and virtual bench testing.
    Mortier P; De Beule M; Dubini G; Hikichi Y; Murasato Y; Ormiston JA
    EuroIntervention; 2010 Dec; 6 Suppl J():J53-60. PubMed ID: 21930491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.